Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Raphaelle El-Habib"'
Autor:
John G. McNeil, Jerome H. Kim, Bruce L. Gilliam, Silvia Ratto-Kim, Jean-Louis Excler, Georgia D. Tomaras, Linda L. Jagodzinski, Deborah L. Birx, Raphaelle El-Habib, Merlin L. Robb, Lindsay Wieczorek, Victoria R. Polonis, Thomas C. VanCott, Robert J. O'Connell, Josephine H. Cox, Nelson L. Michael, Michelle Liu, Robert Paris
Publikováno v:
Journal of Infectious Diseases. 213:1946-1954
Background Prime-boost regimens comprising ALVAC-HIV (prime) and human immunodeficiency virus type 1 (HIV) Env (boost) induce HIV-specific neutralizing antibody and cell-mediated immune responses, but the impact of boost schedule and adjuvant require
Autor:
Sara Crespillo, Francisco Conejero-Lara, Pedro L. Mateo, Bertrand Morel, Salvador Casares, Raphaelle El-Habib, Nicolas Mouz, Frank Notka, Marie G. Roger, Fadia Manssour-Triedo
Publikováno v:
Biophysical journal. 111(4)
The HIV gp41 ectodomain (e-gp41) is an attractive target for the development of vaccines and drugs against HIV because of its crucial role in viral fusion to the host cell. However, because of the high insolubility of e-gp41, most biophysical and str
Autor:
Benoit Delache, Roger Le Grand, Frédéric Martinon, Hugues Fausther Bovendo, Vincent Vieillard, Julie Morin, Bruno Vaslin, Julien Calvo, Patrice Debré, Isabelle Picq, Patricia Brochard, Raphaelle El Habib
Publikováno v:
AIDS. 22:185-192
Objective: HIV-1 infection is characterized by a progressive decline of CD4 cell count, the underlying mechanisms of which are still debated. We recently found that during HIV-1 infection, CD4 T cells overexpress a ligand of the NK activating recepto
Autor:
Maria Beumont-Mauviel, Cécile Goujard, Raphaelle El Habib, Jean-Pierre Aboulker, Vincent Meiffrédy, Jean-François Delfraissy, Houria Hendel-Chavez, Alain Venet, Yves Levy, Yacine Taoufik, Christine Rouzioux, Marianne Burgard, Fabienne Marcellin
Publikováno v:
AIDS Research and Human Retroviruses. 23:1105-1113
HIV-specific T cell responses play a critical role in the control of infection. We evaluated the impact of immune-based interventions in patients first treated during primary HIV-1 infection (PHI). Forty-three patients were randomized within three gr
Autor:
Prasert Thongcharoen, Sanjay Gurunathan, Jerome H. Kim, Victoria R. Polonis, Susan W. Barnett, Chitraporn Karnasuta, Chirasak Khamboonruang, Arthur Brown, Mark de Souza, John G. McNeil, Vinai Suriyanon, Robert Paris, Silvia Ratto-Kim, Raphaelle El Habib, Deborah L. Birx, Lynn Baglyos
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 46:48-55
Background The development of an effective HIV-1 vaccine is critical to control the pandemic. A prime-boost HIV-1 vaccine trial assessing safety and immunogenicity was conducted in Thailand as part of an evaluation of candidate regimens for a phase 3
Autor:
J Michael, Kilby, R Pat, Bucy, Donna, Mildvan, Margaret, Fischl, Jorge, Santana-Bagur, Jeff, Lennox, Chris, Pilcher, Andrew, Zolopa, Jody, Lawrence, Richard B, Pollard, Raphaelle El, Habib, David, Sahner, Lawrence, Fox, Evgenia, Aga, Ronald J, Bosch, Ronald, Mitsuyasu
Publikováno v:
The Journal of Infectious Diseases. 194:1672-1676
Strategies to limit life-long dependence on antiretroviral therapy (ART) are needed. We randomized 81 human immunodeficiency virus (HIV)-infected subjects to 4 interventional arms involving continued ART plus ALVAC vCP1452 (or placebo) with or withou
Autor:
Michele D. Spring, Raphaelle El Habib, Carol Smith, Jorge Flores, David H. Schwartz, Michael C. Keefer, Paul Spearman, Zina Moldoveanu, Paul A. Goepfert, Peter F. Wright, M. Juliana McElrath, Kent J. Weinhold, Yuwei Zhu, Geoffrey J. Gorse, Jiri Mestecky
Publikováno v:
The Journal of Infectious Diseases. 189:1221-1231
Background Since the primary routes of human immunodeficiency type 1 (HIV-1) infection are across mucosal barriers, a randomized trial of canarypox virus-based vectors was conducted in 84 individuals, with delivery of vaccine by mucosal routes, and w
Autor:
Deborah L. Birx, Naomi E. Aronson, Cristin Hill, Silvia Ratto-Kim, Janelle Grimes, Lawrence D. Loomis-Price, Chevelle Williams, Jerome H. Kim, Raphaelle El Habib
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 32:9-17
In this study, we investigated the CD4 + T-helper response induced by ALVAC-HIV(vCP205) ± rgp160MN/LAI-2 using a series of 15 overlapping amino acid peptides spanning the entire gp160MN/LAI-2 antigen. CD4 + Env-specific T-cell lines were established
Autor:
John R. Mascola, Josephine H. Cox, Merlin L. Robb, Pierre A. Caudrelier, Raphaelle El-Habib, Silvia Ratto-Kim, Beatrice Schuler-Thurner, Wendy B. Bernstein, Jeffrey R. Currier, Michael A. Eller, Mark K. Louder, Deborah L. Birx, Ralph M. Steinman, Bruce L. Levine, Carl H. June, Sarah Schlesinger-Frankel, Mary A. Marovich
Publikováno v:
The Journal of Infectious Diseases. 186:1242-1252
Preclinical data are reported that support a human immunodeficiency virus (HIV) vaccine strategy using recombinant canarypox-HIV vectors (ALVAC-HIV) to load human dendritic cells (DCs) with HIV antigens. Clinical-grade DCs were infected with good man
Autor:
Ana Cámara-Artigas, Francisco Conejero-Lara, Bin Su, Bertrand Morel, Raphaelle El Habib, Marie G. Roger, Christophe Martin, Eva S. Cobos, Salvador Casares, Pedro L. Mateo, Nicolas Mouz, Christiane Moog, Sara Crespillo
Publikováno v:
'Proceedings of the National Academy of Sciences of the USA ', vol: 111, pages: 18207-18212 (2014)
During HIV-1 fusion to the host cell membrane, the N-terminal heptad repeat (NHR) and the C-terminal heptad repeat (CHR) of the envelope subunit gp41 become transiently exposed and accessible to fusion inhibitors or Abs. In this process, the NHR regi